KATHRYN WISNEWSKI: Open Payments
NPI 1255065694 · PAWTUCKET, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,854 in 182 payments from 19 companies in 2025. Trend: 2023 $3,462 · 2024 $4,208 · 2025 $3,854
Food & beverage: $3,749Education: $105
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 24 | $674 |
| Novartis Pharmaceuticals Corporation | 24 | $510 |
| ABBVIE INC. | 39 | $470 |
| Janssen Biotech, Inc. | 18 | $427 |
| Arcutis Biotherapeutics, Inc. | 14 | $340 |
| Regeneron Healthcare Solutions, Inc. | 9 | $243 |
| Amgen Inc. | 8 | $181 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $172 |
| Lilly USA, LLC | 8 | $170 |
| UCB, Inc. | 7 | $167 |
Products named: ADBRY, TREMFYA, COSENTYX, Zoryve, DUPIXENT, SKYRIZI, RINVOQ, OTEZLA.
Industry payments across RI — which companies pay providers there.
